>
产品中心 >
clinical_research >
absoluteantibody/Anti-carcinoembryonic antigen (CEA) [Arcitumomab]/50 μg/Ab00281-19.0
![absoluteantibody/Anti-carcinoembryonic antigen (CEA) [Arcitumomab]/50 μg/Ab00281-19.0](https://www.ebiomall.cn/images/no_picture.gif)
UniProt Accession Number of Target Protein: Q13984
Immunogen: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion normally produced in gastrointestinal tissue during fetal development, but only at very low levels in adults.
Specificity: Recognises human carcinoembryonic antigen.
Application Notes: This antibody binds to carcinoembryonic antigen and was used in the diagnosis of mammary carcinomas.
Antibody first published in:Goldenberg DM, Wegener W.Studies of breast cancer imaging with radiolabeled antibodies to carcinoembryonic antigen.Acta Med AustricaPMID:9227788Note on publication:Describes the use of this a radiolabeled version of this antibody in breast cancer imaging.
Immunofluorescent staining of rat pancreas using anti-CEA antibody Ab00281 Formaldehyde-fixed rat pancreas slices were stained with Ab00281-10.0 at 5µg/ml and detected with a FITC-conjugated secondary antibody. Ab00281 shows cross-reactivity with rat.
Immunohistochemical staining of human endometrial cancer using anti-CEA antibody Ab00281 Formalin fixed human endometrial cancer slices werewere stained with a Ab00281-10.0 at 5µg/ml.
